Cargando…

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach

BACKGROUND: Gastrointestinal stromal tumours (GISTs) with high-risk features have poor prognosis even if adjuvant treatment is given. Neoadjuvant imatinib may increase the cure rate by shrinking large GISTs and preserve organ function. METHODS: We conducted an Asian multinational phase II study for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurokawa, Yukinori, Yang, Han-Kwang, Cho, Haruhiko, Ryu, Min-Hee, Masuzawa, Toru, Park, Sook Ryun, Matsumoto, Sohei, Lee, Hyuk-Joon, Honda, Hiroshi, Kwon, Oh Kyoung, Ishikawa, Takashi, Lee, Kyung Hee, Nabeshima, Kazuhito, Kong, Seong-Ho, Shimokawa, Toshio, Yook, Jeong-Hwan, Doki, Yuichiro, Im, Seock-Ah, Hirota, Seiichi, Hahn, Seokyung, Nishida, Toshirou, Kang, Yoon-Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520207/ https://www.ncbi.nlm.nih.gov/pubmed/28535156 http://dx.doi.org/10.1038/bjc.2017.144

Ejemplares similares

Impact of the KIT/PDGFRA genotype on prognosis in imatinib‐naïve Japanese patients with gastrointestinal stromal tumor
por: Cho, Haruhiko, et al.
Publicado: (2021)

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
por: Saito, Yurina, et al.
Publicado: (2019)

Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World
por: Nishida, Toshirou, et al.
Publicado: (2018)

Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
por: Nishida, Toshirou, et al.
Publicado: (2019)

Surgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report
por: Arita, Asami, et al.
Publicado: (2023)

Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib
por: Sawaki, Akira, et al.
Publicado: (2014)

Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors
por: Takahashi, Tsuyoshi, et al.
Publicado: (2017)

Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer
por: Yanagimoto, Yoshitomo, et al.
Publicado: (2023)

Surgical Treatment of Gastroesophageal Junction Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018)

Update on the Treatment of Gastric Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018)

Re‐appraisal of the universal definition of tumor rupture among patients with high‐risk gastrointestinal stromal tumors
por: Gotohda, Naoto, et al.
Publicado: (2023)

The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
por: Nishida, Toshirou, et al.
Publicado: (2015)

Are treatment outcomes in gastric cancer associated with either hospital volume or surgeon volume?
por: Mukai, Yosuke, et al.
Publicado: (2017)

Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma
por: Kurokawa, Yukinori, et al.
Publicado: (2022)

Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan
por: Ichinose, Yuichi, et al.
Publicado: (2022)

Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I
por: Nishida, Toshirou, et al.
Publicado: (2015)

Prospective Observational Study of Imatinib Therapy in Japanese Patients with Advanced Gastrointestinal Stromal Tumors: Long-term Follow-up and Second Malignancy
por: Kanda, Tatsuo, et al.
Publicado: (2012)

Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program
por: Son, Myoung Kyun, et al.
Publicado: (2017)

Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy
por: Sugase, Takahito, et al.
Publicado: (2016)

Imatinib therapy for a patient with metastasis of colonic gastrointestinal stromal tumor: report of a case
por: Okamura, Takuma, et al.
Publicado: (2013)

ALK-positive lung adenocarcinoma in a patient with rheumatoid arthritis with long-term treatment for organizing pneumonia: A case report
por: Horie, Kazuhito, et al.
Publicado: (2022)

Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
por: Park, Sook Ryun, et al.
Publicado: (2016)

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
por: Sawaki, Akira, et al.
Publicado: (2009)

Functional evaluations comparing Billroth I with a large remnant stomach and Roux en Y with a small remnant stomach following laparoscopic distal gastrectomy for gastric cancer: An investigation including laparoscopic total gastrectomy
por: Nomura, Eiji, et al.
Publicado: (2022)

Is simply covering the patient's mouth with a surgical mask during transnasal endoscopy sufficient as an anti-COVID-19 measure?
por: Nose, Yohei, et al.
Publicado: (2023)

The endoluminal pressures during flexible gastrointestinal endoscopy
por: Ushimaru, Yuki, et al.
Publicado: (2020)

Local Resection by Combined Laparoendoscopic Surgery for Duodenal Gastrointestinal Stromal Tumor
por: Kato, Motohiko, et al.
Publicado: (2011)

Differential Expression of CADM1 in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities
por: Yuan, Jiayin, et al.
Publicado: (2021)

Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis
por: Natatsuka, Rie, et al.
Publicado: (2015)

Angiolipoma of the stomach presenting with anaemia
por: Nam, Yang Hoon, et al.
Publicado: (2014)

Laparoscopic resection of locally advanced gastrointestinal stromal tumour (GIST) of the stomach following neoadjuvant imatinib chemoreduction
por: Berney, Christophe R.
Publicado: (2015)

Preoperative imatinib and laparoscopic intersphincteric resection for large rectal gastrointestinal stromal tumor: A case report
por: Nagano, Shinnosuke, et al.
Publicado: (2020)

Imatinib Mesylate-Induced Hyperpigmentation of the Nose and Palate
por: Song, Hyo Sang, et al.
Publicado: (2014)

Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma
por: TAKATA, AKIHIRO, et al.
Publicado: (2014)

A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide
por: Kato, Ryo, et al.
Publicado: (2016)

A case of transvaginal NOTES partial gastrectomy using new techniques and devices
por: Higashi, Shigeyoshi, et al.
Publicado: (2015)

Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis
por: Masuike, Yasunori, et al.
Publicado: (2018)

Validation of new Japanese classification system for esophageal achalasia
por: Kato, Ryo, et al.
Publicado: (2019)

Performing laparoscopic sleeve gastrectomy in an obese patient with systemic lupus erythematosus undergoing long-term steroid therapy: a case report
por: Gakuhara, Atsushi, et al.
Publicado: (2019)

The Role of Endoscopy in the Diagnosis of Gastric Gastrointestinal Stromal Tumors
por: Nishida, Toshirou
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uq3vkkqtgi1to8t9k5opfmq88r